What should an independent clinic have in place before launching a regenerative service line?
Short answer
An independent clinic should have five things in place before launching a regenerative service line, in this order: confirmation of who may perform each part of the service under state law, a documented basis for each product's regulatory status, written protocols and training, compliant patient wording with consent to be contacted, and a way to follow up and count results. The legal and regulatory steps come first because they decide what the rest can say.
1. Confirm scope and structure with your state board and attorney
Who may perform each part of a regenerative service is set by state law, and it differs from state to state. Before anything else:
- Confirm with your state licensing board which licensed professionals may perform each step of the service you plan.
- Ask a healthcare attorney what supervision, delegation or ownership arrangements your state requires if the service needs a provider type your clinic does not have.
- Get both answers in writing and date them.
For chiropractic clinics, How can a chiropractic clinic legally add a regenerative medicine service line? shows how three states' own texts differ.
2. Document each product's regulatory status
An HCT/P is regulated solely under section 361 of the Public Health Service Act only if it meets every criterion in 21 CFR 1271.10(a). For each product, get from the supplier:
- Whether the product is described as a 361 HCT/P or as a licensed 351 product, in writing.
- For a 361 HCT/P, the manufacturer's written basis for each of the four criteria, for the product's labeled use.
- The manufacturing establishment's registration, and check it yourself in FDA's HCTERS public query. Registration is not a determination that a product is appropriately regulated solely under section 361.
- The product's labeling, and its storage and handling instructions.
- Whether the clinic's own activities with the product, such as storage, fall inside an exception in 21 CFR 1271.15. Ask your attorney.
The criteria are explained in What are the FDA 361 HCT/P criteria and what do they mean for clinics?
3. Protocols, training and informed consent
This checklist does not cover clinical content. Protocols, candidacy and technique come from a qualified medical director or provider. Operationally, confirm that:
- Written protocols exist for the service, approved by the provider responsible for them.
- Everyone who takes part has documented training for their role, within their license.
- Your attorney has confirmed what your state requires for informed consent, and the consent form has been reviewed.
- Product handling follows the supplier's written storage and handling instructions.
4. Patient wording and consent to be contacted
- Describe the service, the provider and the visit, not what a product does for a disease or condition.
- Keep product descriptions within the product's labeling and stated uses.
- Check every mention of FDA. Registration is not approval.
- Collect written consent before any text or call, and keep a record of the exact wording the lead saw. Get advice on 47 CFR 64.1200 and related rules from a telecommunications attorney.
The rules behind each of these are in How can a clinic market regenerative services to patients without making claims it cannot support?
5. Patient acquisition and follow up
Before you spend on advertising, confirm that:
- A page exists that describes the service in reviewed wording and lets a patient ask for a consult.
- Someone, or a system, answers new inquiries quickly, and only contacts people who gave consent.
- Every lead's consent, source and contact history is recorded.
- Leads who ask to stop hearing from you are removed from every channel.
6. Count what happens
Decide before launch what you will count each month: inquiries, consults booked, consults attended, and patients who go ahead. Those counts are the only reliable guide to what the service line does for your clinic.
As an illustration only, try a range of 5 to 20 added regenerative patients a month. Multiply the number you choose by your own average revenue per patient and subtract product cost and ad spend to see what a month could look like. Estimates only. Results vary. Not a guarantee.
Sources
- 21 CFR 1271.10, criteria for regulation solely under section 361, eCFR, read on 2026-11-20.
- 21 CFR 1271.15, exceptions, eCFR, read on 2026-11-20.
- FDA: HCTERS Public Query Application, read on 2026-11-20.
- 47 CFR 64.1200, delivery restrictions on calls, eCFR, read on 2026-11-20.
Frequently asked questions
How long does it take to launch a regenerative service line?
There is no fixed timeline. It depends on how long it takes to get answers from your state board and a healthcare attorney about who may perform each part of the service, to get each supplier's documented basis for its products' regulatory status, and to write and review protocols, consent forms and patient wording. Those steps come before any marketing.
Do I need a medical director?
It depends on your state and on what the service involves. Who may perform each part of a service, and what supervision or delegation is required, is set by state law and differs from state to state. Ask your state licensing board and a healthcare attorney before you set up the service.
What should I ask a biologics supplier for?
Ask whether each product is described as a 361 HCT/P or as a licensed 351 product, and get the answer in writing. For a 361 HCT/P, ask for the manufacturer's written basis for each criterion in 21 CFR 1271.10(a) for the product's labeled use, the manufacturing establishment's FDA registration, the labeling, and the storage and handling instructions.
What records should the clinic keep?
Ask your healthcare attorney which records your state and the federal rules require for the activities your clinic will carry out. As a practical baseline, not a legal minimum, keep each supplier's written answers about product status, dated copies of every patient facing message and ad as released, and a record of each lead's consent to be contacted.
How many patients should we plan for?
As an illustration only, try a range of 5 to 20 added regenerative patients a month. Multiply the number you choose by your own average revenue per patient and subtract product cost and ad spend to see what a month could look like. Estimates only. Results vary. Not a guarantee.